World market for personalized medicine diagnostics
1. World Market for Personalized Medicine Diagnostics (Biomarkers,
Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
A special focus of the report is the bustle of activity with collaborations between IVD and
pharmaceutical companies, as well as IVD companies and CLIA labs. This report profiles
scores of such companies operating in this market and estimates and forecasts markets
(where there are products on the market) for personalized medicine technologies in the
following categories:
Cardiac Markers, immunoassays
Cardiac Risk Markers
Cardiac markers, molecular
Coagulation, routine
Coagulation, molecular
Cancer, Tumor Markers
Cancer, Molecular
Cancer, Tissue-based
Psychiatric Disorders
Diabetes, BGM
Diabetes, HbA1c
Microbiology, ID/AST
Infectious Diseases, Viral Load (HIV, HCV, HBV)
Infectious Diseases, other
Blood Bank Molecular
Transplant Tissue Typing
Lab Developed Tests
Request a Sample for or Inquire before buying the report Personalized Medicine
Diagnostics Market
In this market research report, Kalorama Information defines the current opportunity and a
realistic future potential for personalized medicine in clinical testing. In addition to analysis
of tests currently on the market and in development, the report profiles key competitors
and discusses trends that are important for understanding this much-discussed growth area
of the diagnostic industry.
Developments that are linked in the press to 'personalized medicine' are many, and can at
times be confusing. But there are several discovered biomarkers that are important in
diagnostic markets.
Biomarkers discussed in the report include:
Cytochrome P450 and Drug Metabolism
Estrogen Receptor and Progesterone
Receptor Status for Breast Cancer
HER2 Overexpression and Herceptin and Tykerb
Epidermal Growth Factor Receptor (EGFR)
KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
2. BRAF Mutations and Cancer Therapy
UGT1A1 Genetic Variants
5-Flurouracil Therapy
PIK3CA Genetic Variation
KIF6 Genetic Variation
ALK Genetic Variation
Major points covered in Table of Contents of this report include:
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: INTRODUCTION
CHAPTER THREE: STRATEGIC ISSUES: THE “COMMERCIALIZATION CONDUNDRUM”
CHAPTER FOUR: DISEASE TARGETS
CHAPTER FIVE: DIAGNOSTIC TECHNOLOGIES
CHAPTER SIX: MARKET ANALYSIS
CHAPTER SEVEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS
CHAPTER EIGHT: COMPANY PROFILES
List of Tables
Explore Reports related to Biotechnology @ http://www.reportsnreports.com/market-
research/biotechnology/
Report Details:
Published: March 2012
No. of Pages: 430
Price: Single User License – US$3795 Corporate User License – US$7590
Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect With Us: